Columbia Financial (CLBK) CEO details deferred stock, awards and options
Rhea-AI Filing Summary
Columbia Financial, Inc.'s President and CEO, who is also a director, reported acquiring 104.3884 phantom common stock units through the Columbia Bank Stock Based Deferral Plan on December 12, 2025 at $17.12 per unit. This transaction increased the reporting person's stock-based deferral plan balance to 66,378.1868 units, which will be settled in shares of stock upon distribution.
The report also outlines the reporting person's broader ownership in Columbia Financial common stock, including 233,808 shares held directly and additional indirect holdings through retirement and incentive plans and by a spouse. Under the 2019 Equity Incentive Plan, the reporting person holds stock options covering 656,471 shares at a $15.6 exercise price that are fully vested and exercisable, plus further option grants over 37,894, 37,168 and 94,749 shares at exercise prices of $15.94, $16.49 and $16.23, vesting in three approximately equal annual installments beginning in 2024, 2025 and 2026.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Columbia Financial (CLBK) report for its President and CEO?
The reporting person, who is President & CEO and a director of Columbia Financial, Inc. (CLBK), reported acquiring 104.3884 phantom common stock units on December 12, 2025 at a price of $17.12 per unit through the Columbia Bank Stock Based Deferral Plan.
How many deferred stock units does the Columbia Financial (CLBK) insider hold after this transaction?
Following the reported transaction, the reporting person beneficially owns 66,378.1868 stock-based deferral plan units, held indirectly under the Columbia Bank Stock Based Deferral Plan. These stock unit interests will be settled in shares of Columbia Financial stock upon distribution.
How many Columbia Financial (CLBK) common shares does the insider hold directly and indirectly?
The reporting person holds 233,808 Columbia Financial common shares directly. Indirect holdings include 40,946 shares through a 401(k), 7,620 shares through an ESOP, 32,597 shares through a SERP, 41,572 shares through a SIM, 5,933 shares held by a spouse, and stock awards of 43,411, 50,686 and 54,690 shares under various equity award tranches.
What stock options does the Columbia Financial (CLBK) insider hold and at what exercise prices?
The reporting person holds several stock option grants under the 2019 Equity Incentive Plan. These include 656,471 options with a $15.6 exercise price that are fully vested and exercisable and expire on July 23, 2029. Additional grants cover 37,894 shares at $15.94 (exercisable from May 1, 2024, expiring May 1, 2033), 37,168 shares at $16.49 (exercisable from March 6, 2025, expiring March 6, 2034), and 94,749 shares at $16.23 (exercisable from March 3, 2026, expiring March 3, 2035).
What is the Columbia Bank Stock Based Deferral Plan mentioned in the CLBK insider report?
The Columbia Bank Stock Based Deferral Plan is described as a non-qualified stock-based deferral plan. Phantom stock is purchased on a non-discretionary basis by the trustee of the bank's rabbi trust, and stock unit interests under the plan are settled in shares of Columbia Financial stock upon distribution to the reporting person.
How do the Columbia Financial (CLBK) performance-based stock awards for the insider vest?
Stock Awards II and III were granted under the 2019 Equity Incentive Plan. For each, 25% vests in three approximately equal annual installments (beginning on May 1, 2024 for Award II and March 6, 2025 for Award III), while the remaining 75% vests upon achievement of specified performance-based criteria, with vesting three years after the award date if those criteria are met. Stock Award IV also vests upon achievement of performance-based criteria, with vesting three years after the award date on March 3, 2028.